section name header

Y-Site Injection Compatibility (1:1 Mixture)

Gentamicin sulfate

(Mfr: FRK)(Conc: 5 mg/mLa)

QMark

Imipenem-cilastatin sodium-relebactam

(Mfr: ME)(Conc: 5 mg/mLjj)

Remarks:

Visually compatible; pH increased by >1 unit within 2 hr

Ref:

3604